News Focus
News Focus
Post# of 257262
Next 10
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

Re: bladerunner1717 post# 140270

Monday, 04/16/2012 3:41:17 PM

Monday, April 16, 2012 3:41:17 PM

Post# of 257262
I didn't listen to the call. From press release, ECYT fund and finish ph3 OC trial which is a relatively large trial, MRK basically take over everything else. NSCLC ph2 is a much smaller trial. It would be interesting to see what MRK do.

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now